Author:
Agabiti-Rosei Enrico,Martino Stefania,Torlone Francesco,Agabiti-Rosei Claudia
Publisher
Springer International Publishing
Reference43 articles.
1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.
2. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Writing Committee Members, et al. AHA/ACC/HFSA guideline for the management of heart failure. Circulation. 2022;2022(145):e895–e1032.
3. Kasiakogias A, Agabiti-Rosei E, Camafort M, Ehret G, Faconti L, Ferreira JP, Brguljan J, Januszewicz A, Kahan T, Manolis A, Tsioufis K, Weber T, von Lueder TG, Smiseth OA, Wachtell K, Kjeldsen SE, Zannad F, Mancia G, Kreutz R. Hypertension and heart failure with preserved ejection fraction: position paper by the European society of hypertension. J Hypertens. 2021;39(8):1522–45.
4. Gevaert AB, Kataria R, Zannad F, Sauer AJ, Damman K, Sharma K, Shah SJ, Van Spall HGC. Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management. Heart. 2022;108(17):1342–50.
5. Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, et al. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. 2018;39:26–35.